Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 2,457 | 1,840 | 3,802 | 2,358 | 1,740 |
| Gross Profit | 2,457 | 1,840 | 3,802 | 2,358 | 1,740 |
| Operating Expenses | 13,469 | 10,172 | 13,955 | 12,358 | 9,744 |
| Operating Income | -11,012 | -8,331 | -10,153 | -10,000 | -8,004 |
| Other Income | 3,599 | 1,152 | -565 | -831 | -7,464 |
| Pre-tax Income | -7,413 | -7,179 | -10,718 | -10,831 | -15,468 |
| Net Income Continuous | -7,413 | -7,179 | -10,718 | -10,831 | -15,468 |
| Minority Interests | -4 | 2 | -6 | -9 | -14 |
| Net Income | $-7,408 | $-7,181 | $-10,711 | $-10,822 | $-15,454 |
| EPS Basic Total Ops | -1.32 | -1.44 | -2.16 | -2.40 | -3.72 |
| EPS Basic Continuous Ops | -1.42 | -1.43 | -2.14 | -2.36 | -3.86 |
| EPS Diluted Total Ops | -1.56 | -1.44 | -2.28 | -2.40 | -3.72 |
| EPS Diluted Continuous Ops | -1.40 | -1.42 | -2.13 | -2.36 | -3.86 |
| EBITDA(a) | $-10,529 | $-7,912 | $-9,787 | $-9,645 | $-7,362 |